Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

A GLP-1 agonist is a medication that mimics glucagon-like peptide-1, a hormone your gut naturally produces after eating. These drugs slow stomach emptying, increase feelings of fullness, and help regulate blood sugar—making them powerful tools for weight management. PlexusDx provides compounded GLP-1 therapies from licensed 503A pharmacies, available in all 50 states without insurance.

How GLP-1 Agonist Medications Work in Your Body

GLP-1 agonists bind to specific receptors in your brain, pancreas, and digestive tract, triggering multiple metabolic responses. When you eat, your gut naturally releases GLP-1 to signal satiety and regulate insulin release. GLP-1 medications amplify these signals, causing your stomach to empty more slowly and reducing your appetite by up to 30% in clinical studies. This multi-system effect makes GLP-1 agonists different from older weight-loss drugs that target only one pathway.

The medications also improve how your pancreas responds to blood sugar changes. Your beta cells release more insulin when glucose is high and less when it's low—a process called glucose-dependent insulin secretion. This precision reduces the risk of dangerously low blood sugar compared to some older diabetes medications. Over time, consistent GLP-1 activation can help normalize your body's hunger signals and metabolic set point.

Semaglutide vs. Tirzepatide: Understanding Two GLP-1 Options

Semaglutide and tirzepatide are both GLP-1 agonists, but tirzepatide is a dual agonist—it also activates GIP receptors. GIP (glucose-dependent insulinotropic polypeptide) is another gut hormone that controls appetite and glucose metabolism. In head-to-head trials, tirzepatide showed slightly greater weight loss than semaglutide alone, with some patients losing up to 22% of body weight over 68 weeks. Semaglutide remains highly effective and is often preferred as a first-line option due to its established safety profile and lower cost.

PlexusDx offers both as compounded injections and oral formulations. Compounded Semaglutide Injection starts at $149/mo, while Compounded Tirzepatide Injection starts at $249/mo. For patients who prefer oral medications, Oral Semaglutide begins at $249/mo and Oral Tirzepatide at $279/mo. Your dose may need to go up. Your price won't. The choice between them depends on your metabolic profile, tolerance, and response—something PlexusDx clinicians assess during onboarding.

GLP-1 Genetic Testing: Personalizing Your Therapy

Not everyone responds equally to GLP-1 agonists because genetic variation affects how your body produces and uses these hormones. Key genes like GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) influence appetite regulation and medication response. Some patients have genetic variants that make them better responders to tirzepatide's dual action, while others show optimal results with semaglutide alone. PlexusDx Precision Peptide Genetic Test maps 14 pathways and 49 peptides to reveal your personal peptide blueprint.

The test costs $99 as an add-on after your first month of treatment and provides actionable insights into which compound and formulation may work best for your genetics. This isn't pharmacogenomics (drug metabolism testing)—it's peptide-pathway genetics that directly predict your hormonal response to GLP-1 therapy. Armed with this data, PlexusDx clinicians can optimize your medication choice and dosing strategy for faster, more sustainable results. Testing is available to all patients across all 50 states.

Safety, Side Effects, and What to Expect Starting GLP-1

The most common side effects of GLP-1 agonists are nausea, vomiting, and constipation, usually mild and dose-dependent. These typically peak in the first 2–4 weeks and improve as your body adjusts. Clinical trials show that serious adverse events are rare, with the safety profiles of semaglutide and tirzepatide well-established over years of real-world use. Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN2) should not use GLP-1 agonists.

PlexusDx medications come from licensed 503A compounding pharmacies and are dispensed with detailed patient education on injection technique, storage, and symptom management. All therapies are HSA/FSA eligible, and no membership or insurance is required. Your clinician will monitor your progress monthly and adjust your dose gradually—starting low and titrating up to minimize side effects while maximizing efficacy. Most patients report significant appetite reduction and steady weight loss within 6–8 weeks of consistent treatment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with a GLP-1 agonist?

Most patients notice reduced appetite within 1–2 weeks and measurable weight loss within 4–6 weeks of starting treatment. PlexusDx clinicians recommend patience during the titration phase, as doses are increased gradually every 4 weeks. Results accelerate as your dose reaches your therapeutic level, typically between weeks 8–12.

Can I switch between semaglutide and tirzepatide if one doesn't work?

Yes, switching between GLP-1 compounds is possible and sometimes beneficial if you experience poor tolerance or suboptimal response. PlexusDx Precision Peptide Genetic Test results help predict which compound you're more likely to respond to, reducing trial-and-error. If you do switch, your clinician will guide you through a safe transition protocol.

Does PlexusDx require insurance, and are treatments covered?

No insurance is required to use PlexusDx. Compounded semaglutide and tirzepatide are not typically covered by insurance because they're from licensed 503A pharmacies, not pharmaceutical manufacturers. However, all therapies are HSA/FSA eligible, and PlexusDx pricing starts at $129/mo for the Microdose GLP-1 Protocol and $149/mo for Semaglutide Injection.

Are there any groups who shouldn't use GLP-1 medications?

Patients with personal or family history of medullary thyroid cancer, MEN2 syndrome, or severe pancreatitis should not use GLP-1 agonists. Pregnant patients or those planning pregnancy should discuss GLP-1 use with their clinician. Your PlexusDx medical team will review your full health history during your initial consultation to ensure safety.

What does the PlexusDx Precision Peptide Genetic Test reveal?

The $99 test analyzes how genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 other pathways affect your appetite regulation and medication response. Results map 49 peptides and 150+ genetic insights to help your clinician choose between semaglutide, tirzepatide, or dual-compound therapy. Testing is available after one month of treatment and available nationwide.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves